1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar
|
2
|
De Angelis R, Sant M, Coleman MP,
Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H,
Ardanaz E, et al: Cancer survival in Europe 1999-2007 by country
and age: Results of EUROCARE-5-a population-based study. Lancet
Oncol. 15:23–34. 2014. View Article : Google Scholar
|
3
|
He Q, Long J, Yin Y, Li Y, Lei X, Li Z and
Zhu W: Emerging roles of lncRNAs in the formation and progression
of colorectal cancer. Front Oncol. 9:15422020. View Article : Google Scholar
|
4
|
Luo Y, Yang J, Yu J, Liu X, Yu C, Hu J,
Shi H and Ma X: Long non-coding RNAs: Emerging roles in the
immunosuppressive tumor microenvironment. Front Oncol. 10:482020.
View Article : Google Scholar
|
5
|
Xu J, Meng Q, Li X, Yang H, Xu J, Gao N,
Sun H, Wu S, Familiari G, Relucenti M, et al: Long noncoding RNA
MIR17HG promotes colorectal cancer progression via miR-17-5p.
Cancer Res. 79:4882–4895. 2019. View Article : Google Scholar
|
6
|
Xiao Z, Qu Z, Chen Z, Fang Z, Zhou K,
Huang Z, Guo X and Zhang Y: LncRNA HOTAIR is a prognostic biomarker
for the proliferation and chemoresistance of colorectal cancer via
miR-203a-3p-mediated Wnt/ß-catenin signaling pathway. Cell Physiol
Biochem. 46:1275–1285. 2018. View Article : Google Scholar
|
7
|
Ding D, Li C, Zhao T, Li D, Yang L and
Zhang B: LncRNA H19/miR-29b-3p/PGRN axis promoted
epithelial-mesenchymal transition of colorectal cancer cells by
acting on Wnt signaling. Mol Cells. 41:423–435. 2018.
|
8
|
Williams GT and Farzaneh F: Are snoRNAs
and snoRNA host genes new players in cancer? Nat Rev Cancer.
12:84–88. 2012. View Article : Google Scholar
|
9
|
Shan Y, Ma J, Pan Y, Hu J, Liu B and Jia
L: LncRNA SNHG7 sponges miR-216b to promote proliferation and liver
metastasis of colorectal cancer through upregulating GALNT1. Cell
Death Dis. 9:7222018. View Article : Google Scholar
|
10
|
Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B
and Jia L: Long non-coding RNA-SNHG7 acts as a target of miR-34a to
increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in
colorectal cancer progression. J Hematol Oncol. 11:892018.
View Article : Google Scholar
|
11
|
Ota T, Suzuki Y, Nishikawa T, Otsuki T,
Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al:
Complete sequencing and characterization of 21,243 full-length
human cDNAs. Nat Genet. 36:40–45. 2004. View Article : Google Scholar
|
12
|
Zhang PF, Wu J, Luo JH, Li KS, Wang F,
Huang W, Wu Y, Gao SP, Zhang XM and Zhang PN: SNHG22 overexpression
indicates poor prognosis and induces chemotherapy resistance via
the miR-2467/Gal-1 signaling pathway in epithelial ovarian
carcinoma. Aging (Albany NY). 11:8204–8216. 2019. View Article : Google Scholar
|
13
|
Fang X, Zhang J, Li C, Liu J, Shi Z and
Zhou P: Long non-coding RNA SNHG22 facilitates the malignant
phenotypes in triple-negative breast cancer via sponging miR-324-3p
and upregulating SUDS3. Cancer Cell Int. 20:2522020. View Article : Google Scholar
|
14
|
Gao H, Sun X, Wang H and Zheng Y: Long
noncoding RNA SNHG22 increases ZEB1 expression via competitive
binding with microRNA-429 to promote the malignant development of
papillary thyroid cancer. Cell Cycle. 19:1186–1199. 2020.
View Article : Google Scholar
|
15
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene F and Trotti A: AJCC cancer staging handbook. 7th edition.
Springer; New York, NY: 2010
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
17
|
Du Y, Wei N, Hong J and Pan W: Long
non-coding RNASNHG17 promotes the progression of breast cancer by
sponging miR-124-3p. Cancer Cell Int. 20:402020. View Article : Google Scholar
|
18
|
National Research Council (US) Committee
for the Update of the Guide for the Care and use of Laboratory
Animals: Guide for the care and use of laboratory animals. 8th
edition. National Academies Press (US); Washington, DC: 2011
|
19
|
Cao Z, Pan X, Yang Y, Huang Y and Shen HB:
The lncLocator: A subcellular localization predictor for long
non-coding RNAs based on a stacked ensemble classifier.
Bioinformatics. 34:2185–2194. 2018. View Article : Google Scholar
|
20
|
Lan Y, Xiao X, He Z, Luo Y, Wu C, Li L and
Song X: Long noncoding RNA OCC-1 suppresses cell growth through
destabilizing HuR protein in colorectal cancer. Nucleic Acids Res.
46:5809–5821. 2018. View Article : Google Scholar
|
21
|
Wang Y, Lu JH, Wu QN, Jin Y, Wang DS, Chen
YX, Liu J, Luo XJ, Meng Q, Pu HY, et al: LncRNA LINRIS stabilizes
IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
Mol Cancer. 18:1742019. View Article : Google Scholar
|
22
|
Wang D, Zhang H, Fang X, Zhang X and Liu
H: Prognostic value of long non-coding RNA GHET1 in cancers: A
systematic review and meta-analysis. Cancer Cell Int. 20:1092020.
View Article : Google Scholar
|
23
|
Xiao M, Feng Y, Liu C and Zhang Z:
Prognostic values of long noncoding RNA PVT1 in various carcinomas:
An updated systematic review and meta-analysis. Cell Prolif.
51:e125192018. View Article : Google Scholar
|
24
|
Yang W, Zhang K, Li L, Ma K, Hong B, Gong
Y and Gong K: Discovery and validation of the prognostic value of
the lncRNAs encoding snoRNAs in patients with clear cell renal cell
carcinoma. Aging (Albany NY). 12:4424–4444. 2020. View Article : Google Scholar
|
25
|
Li M, Bian Z, Jin G, Zhang J, Yao S, Feng
Y, Wang X, Yin Y, Fei B, You Q and Huang Z: LncRNA-SNHG15 enhances
cell proliferation in colorectal cancer by inhibiting miR-338-3p.
Cancer Med. 8:2404–2413. 2019. View Article : Google Scholar
|
26
|
Yan J, Jia Y, Chen H, Chen W and Zhou X:
Long non-coding RNA PXN-AS1 suppresses pancreatic cancer
progression by acting as a competing endogenous RNA of miR-3064 to
upregulate PIP4K2B expression. J Exp Clin Cancer Res. 38:3902019.
View Article : Google Scholar
|
27
|
Chen DL, Lu YX, Zhang JX, Wei XL, Wang F,
Zeng ZL, Pan ZZ, Yuan YF, Wang FH, Pelicano H, et al: Long
non-coding RNA UICLM promotes colorectal cancer liver metastasis by
acting as a ceRNA for microRNA-215 to regulate ZEB2 expression.
Theranostics. 7:4836–4849. 2017. View Article : Google Scholar
|
28
|
Zhao J, Li D and Fang L: MiR-128-3p
suppresses breast cancer cellular progression via targeting LIMK1.
Biomed Pharmacother. 115:1089472019. View Article : Google Scholar
|
29
|
Liu X, Dong C, Ma S, Wang Y, Lin T, Li Y,
Yang S, Zhang W, Zhang R and Zhao G: Nanocomplexes loaded with
miR-128-3p for enhancing chemotherapy effect of colorectal cancer
through dual-targeting silence the activity of PI3K/AKT and MEK/ERK
pathway. Drug Deliv. 27:323–333. 2020. View Article : Google Scholar
|
30
|
Liu T, Zhang X, Du L, Liu X, Tian H, Wang
L, Li P, Zhao Y, Duan W, Xie Y, et al: Exosome-transmitted
miR-128-3p increase chemosensitivity of oxaliplatin-resistant
colorectal cancer. Mol Cancer. 18:432019. View Article : Google Scholar
|
31
|
Li X, Lv X, Li Z, Li C, Li X, Xiao J, Liu
B, Yang H and Zhang Y: Long noncoding RNA ASLNC07322 functions in
VEGF-C expression regulated by smad4 during colon cancer
metastasis. Mol Ther Nucleic Acids. 18:851–862. 2019. View Article : Google Scholar
|
32
|
Fu C, Li D, Zhang X, Liu N, Chi G and Jin
X: LncRNA PVT1 facilitates tumorigenesis and progression of glioma
via regulation of MiR-128-3p/GREM1 axis and BMP signaling pathway.
Neurotherapeutics. 15:1139–1157. 2018. View Article : Google Scholar
|
33
|
Wang H, Wang L, Zhang S, Xu Z and Zhang G:
Downregulation of LINC00665 confers decreased cell proliferation
and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
Biomed Pharmacother. 127:1102142020. View Article : Google Scholar
|
34
|
Chen J, Liu X, Xu Y, Zhang K, Huang J, Pan
B, Chen D, Cui S, Song H, Wang R, et al: TFAP2C-activated MALAT1
modulates the chemoresistance of docetaxel-resistant lung
adenocarcinoma cells. Mol Ther Nucleic Acids. 14:567–582. 2019.
View Article : Google Scholar
|